Q3 2023 EPS Estimates for Waters Co. Decreased by Analyst (NYSE:WAT)

Waters Co. (NYSE:WATFree Report) – Analysts at KeyCorp reduced their Q3 2023 earnings estimates for shares of Waters in a note issued to investors on Wednesday, August 2nd. KeyCorp analyst P. Knight now expects that the medical instruments supplier will earn $2.58 per share for the quarter, down from their previous estimate of $2.90. The consensus estimate for Waters’ current full-year earnings is $12.25 per share. KeyCorp also issued estimates for Waters’ FY2023 earnings at $12.20 EPS, FY2024 earnings at $13.30 EPS and FY2025 earnings at $15.00 EPS.

Waters (NYSE:WATGet Free Report) last posted its earnings results on Wednesday, August 2nd. The medical instruments supplier reported $2.80 EPS for the quarter, topping the consensus estimate of $2.59 by $0.21. Waters had a net margin of 22.54% and a return on equity of 141.19%. The firm had revenue of $740.58 million during the quarter, compared to analysts’ expectations of $733.51 million.

Several other research analysts have also recently commented on WAT. Robert W. Baird decreased their target price on shares of Waters from $345.00 to $288.00 in a research report on Wednesday, May 10th. Bank of America lowered their price target on Waters from $350.00 to $315.00 in a research report on Wednesday, May 10th. Stifel Nicolaus cut their price objective on Waters from $345.00 to $315.00 in a report on Wednesday, May 10th. StockNews.com lowered Waters from a “buy” rating to a “hold” rating in a report on Friday, May 12th. Finally, Wells Fargo & Company reduced their price objective on shares of Waters from $345.00 to $305.00 in a research report on Wednesday, May 10th. Eight research analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $327.60.

Waters Price Performance

NYSE WAT opened at $289.94 on Friday. Waters has a 52 week low of $248.18 and a 52 week high of $353.70. The company has a current ratio of 2.21, a quick ratio of 1.59 and a debt-to-equity ratio of 2.38. The stock has a market cap of $17.12 billion, a price-to-earnings ratio of 25.57, a price-to-earnings-growth ratio of 3.35 and a beta of 0.86. The company has a 50-day moving average price of $268.11 and a two-hundred day moving average price of $294.03.

Institutional Trading of Waters

Large investors have recently added to or reduced their stakes in the company. ANTIPODES PARTNERS Ltd acquired a new stake in Waters in the first quarter valued at approximately $25,000. PSI Advisors LLC bought a new stake in Waters during the 2nd quarter worth approximately $26,000. Cascade Investment Advisors Inc. acquired a new stake in shares of Waters in the 1st quarter valued at approximately $31,000. Clear Street Markets LLC increased its position in Waters by 94.9% during the 1st quarter. Clear Street Markets LLC now owns 115 shares of the medical instruments supplier’s stock worth $36,000 after buying an additional 56 shares during the period. Finally, Graham Capital Wealth Management LLC acquired a new stake in Waters in the first quarter valued at about $387,038,000. 90.09% of the stock is owned by institutional investors and hedge funds.

About Waters

(Get Free Report)

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Stories

Earnings History and Estimates for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.